An improved human-derived analog bt Cry toxin protein functional effector (GGCC) and its design method and application
A human-derived, insecticidal protein technology, applied in the field of genetic engineering and biological control, can solve problems such as unreported, and achieve the effect of less harm to human body
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
preparation example Construction
[0042] In the present invention, the preparation method of the human-derived molecularly modified insecticidal protein GGCC_scFv is preferably prepared by a recombinant expression method. The method for preparing human-derived molecularly modified insecticidal proteins by the recombinant expression method preferably includes the following steps:
[0043] (1) Carry out double digestion and ligation of the gene encoding the modified insecticidal protein GGCC_scFv encoding the human molecule and the vector respectively, to obtain the recombinant vector;
[0044] (2) The recombinant vector is introduced into the expression system, induced and cultured, and the recombinantly expressed human-derived molecularly modified insecticidal protein GGCC_scFv is obtained.
[0045] In the present invention, the expression system is preferably a prokaryotic cell expression system. The prokaryotic expression system is preferably Escherichia coli. The strain of Escherichia coli is preferably E...
Embodiment 1
[0068] A method for designing and preparing a human-derived molecularly modified insecticidal protein, the specific steps are as follows:
[0069] (1) Perform BLAST comparison analysis on the amino acid sequences of anti-Cry1Ab toxin idiotype single-chain antibody B12_scFv and Cry1A toxoids (Cry1Aa, Cry1Ab, Cry1Ac), and analyze the similar sequences of B12 and Cry1A toxoids, respectively H-CDR 1, L -CDR 1, L-CDR 2 and GS-linker. The amino acid sequences of anti-Cry1Ab toxin idiotype monoclonal antibody G1_scFv and Cry1B toxoid were compared by BLAST analysis, and the similar sequences of G1 and Cry1B toxoid were analyzed, which were H-CDR1', H-CDR3', and L-CDR 2', respectively.
[0070] (2) Design splicing according to the results, and replace the heavy chain region (VH) of the anti-Cry1Ab toxin idiotype single chain antibody B12_scFv sequence with the heavy chain region (VH) of G1_scFv to obtain the recombinant antibody GGCC_scFv; or use the anti-Cry1Ab toxin idiotype The li...
Embodiment 2
[0077] Anti-CrylAb toxin idiotype single chain antibody B12_scFv, G1_scFv, modified GGCC_scFv, CCGG_scFv and Cry1A toxoids (Cry1Aa, Cry1Ab, Cry1Ac) were compared with the amino acid sequences of Cry1B toxin by BLAST analysis:
[0078] Anti-CrylAb toxin idiosyncratic single-chain antibody B12 (hereinafter referred to as B12_phage, derived from the phage vector pIT2, is a phage-displayed single-chain antibody (scFv), that is, a scFv co-expressed on the GIII protein of the phage coat, such as figure 1 The amino acid sequence shown on the upper left side) has been disclosed by the Chinese patent No. ZL201410037000.9. B12_scFv is the antibody sequence in B12_phage, which is recombined into the prokaryotic expression vector pET-26b for soluble expression of scFv, such as figure 1 Shown above middle.
[0079] Anti-CrylAb toxin idiosyncratic single-chain antibody G1 (hereinafter referred to as G1_phage, derived from the phage vector pIT2, is a phage-displayed single-chain antibody (sc...
PUM
Login to View More Abstract
Description
Claims
Application Information
Login to View More 


